chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Headaches; Body aches; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headaches) and MYALGIA (Body aches) in a 77-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEADACHE (Headaches) and MYALGIA (Body aches). At the time of the report, HEADACHE (Headaches) and MYALGIA (Body aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Reporter did not allow further contact
Swelling around injection site to the size of an apple, itching, pain, hot to the touch.
Increasing redness and pain in arm at  injection site and spreading from site started 1 cm x 1 cm enlarged to 1.5 cm x 2.5 cm with my measurements.before tx recieved. Nausea,gassy.  Later in day flushed face,temp increasing,chills. My normal temp 96-97 ,went up to  99.
Information has been received from a physician through the Merck pregnancy registry for GARDASIL concerning a 27 year old female who on 29-MAY-2008, was vaccinated with the first dose of GARDASIL, 0.5ml, IM and is now pregnant.  On 08-MAY-2008, the patient had her last menstrual period (LMP) (estimated date of delivery 12-FEB-2009).  On 14-JUL-2008, the patient was experiencing a miscarriage.  The patient sought medical attention at the physician's office.  On 14-JUL-2008, the patient was scheduled for a Dilation and Curettage (D&C) procedure.  At the time of reporting, the outcome was unknown.  Upon internal review, miscarriage was considered to be an other important medical event.  Additional information has been requested.
48 hours after vaccine to 72 hours after vaccine: nickel-sized red area on left bicep, not at injection site 72 hours after vaccine to current: ?off? feeling with heaviness in nose and fullness in both ears
Rash; This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of RASH (Rash) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, the patient experienced RASH (Rash). At the time of the report, RASH (Rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment medication was not provided.   Reporter did not allow further contact
I received the Johnson&Johnson vaccine on Friday, May 28th...within 6 hours of receiving it, I was experiencing nausea, chills and fever. It rapidly progressed within 3 hours to the point where my entire left side was numb and I had foot droop, slurred speech and a severe migraine, often associated with a stroke. I was immediately taken to the ER where a CT of my brain, labs, and EKGs were performed due to symptoms I was experiencing closely related to neurological issues. All came back normal, but my left side numbness didn?t subside, nor did any other symptoms mentioned above, even with medications. I was transferred to another hospital to see a neurologist where they ordered an MRI of the brain and more labs and admission into the hospital for observation. Everything came back normal again but still unable to walk and use my left side. It came down to a diagnosis of a hemiplegic migraine, which is a rare and serious form of a migraine with symptoms mimicking a stroke. I was discharged 3 days later and was told to follow up with my primary care doctor and neurologist for further long term care....4 days later and I?m finally able to walk but definitely no where?s near my normal self. Very weak and experiencing many migraines a day
Started with body pains a few hours after injection. The next day I had chest pain but more like muscle chest pain.. took Tylenol with no relief. My bank gave out 2 days after vaccine without doing anything. I was just standing and it went out. My left low back became a little swollen and could not stand straight. The chest muscle pain is still happening. I was just prescribed muscle relaxers
Pt developed rash/hives on legs and buttocks approx 24-48hr after vaccination. No trouble breathing, shortness of breath or other symptoms.  Follow-up - Update Pt's last name. Record updated.
On day of vaccination, he developed redness and swelling in the left deltoid (site of injection).  The following day his left arm was markedly swollen (6cm larger circumference than other side) and the redness/swelling had spread to include circumferential arm from upper shoulder to elbow.  Also had 2 episodes of vomiting on day after vaccine.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 72-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 13Jan2021 at 08:00 as dose 1, single (Lot number: EL1283), in left arm, on 12Feb2021 at 08:00 as dose 2, single (Lot number: EN5318), in left arm and on 11Oct2021 at 10:00 as dose 3 (booster), single (Lot number: FH8027) at the age of 71 years, in left arm for covid-19 immunisation. The patient had no relevant medical history. The patient has no known allergy. The patient's concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Positive, notes: Treatment of COVID-19; (19Sep2022) Negative, notes: tested negative 19Sep2022; (21Sep2022) Positive, notes: On 21Sep started to have congestion again and tested positive. Therapeutic measures were taken as a result of vaccination failure, covid-19 which included Paxlovid (Treatment start date: 17Sep2022; Treatment stop date: 21Sep2022).
Pain and inflammation of the right arm for about one week. Persistent tiredness that continues to this day.
Local severe reaction.  Pain and tenderness extending from elbow to right side of neck with limitation of movement of right arm.  Pain not responsive to over-the counter meds.  Headache, malaise.
Information has been received from a medical assistant concerning a female who was vaccinated with varicella virus vaccine live (Oka/Merck) (Lot # 657941/0851U) 0.5 mL second dose. The medical assistant is reporting the patient developed an injection site reaction after the second dose. The symptoms were described as a "big red rash" at the site. The rash is described as puffy and big circle. The physician has prescribed a medication for the symptoms. It was reported that the patient was recovering and sought unspecified advice. The patient also had a PPD done on 13-AUG-2007 which was read on 15-AUG-2007 (results not provided). This is one of five reports from the same source. The physician reported that these patients had similar reactions after their second doses of varicella virus vaccine. The physician has decided not to vaccinate patient's with the second dose due to these experiences. Additional information has been requested.
Abdominal flu-like symptoms, including nausea to the point of being able to keep down only four bites of food that day, exhaustion, body aches.
Localized swelling to left arm and elbow.  No s/s of infection, NL CBC.  Tx with Ace wrap and observation.
Information has been received from a physician and a medical assistant concerning a 24 year old female with no pertinent medical history and no drug reactions/allergies who was vaccinated with 3 doses of GARDASIL (lot # not reported) at unspecified physician's office and currently was positive for high risk HPV. Concomitant therapy included unspecified birth control. Papanicolaou (PAP) test was performed, result not provided. The patient's positive for high risk HPV persisted at the time of this report. The patient sought medical attention by office visit. Additional information has been requested.
Child in for vaccinations, she had 2 shots, stood up so her brother could sit and get his when she vomited X 3, pale, diaphroetic,  comfort measures with quick recovery,  phone call next day, child was fine after she left clinic, doing well today
Extreme overall muscle pain, tachycardia, rapid heartbeat constantly lasting over 24 hours
Mom reports hive like rash on (L) thigh today (2-7-13). Dt given 2/4/13. Changed to Dt after reaction to PEDIARIX 10/15/12. At that event child had fever and cried for 7 hours.
pt had recent admission for COVID pneumonia; had a positive COVID test on 2/3/22; was dc'd from hospital on 2/5/22 with ABX and prednisone; back to hospital on 2/10/22 with increasing SOB; respiratory failure secondary to COVID pneumonia and PE; given Remdesivir, Decadron, ABX, albuterol inhalers; DNR/DNI; pt states she's tired and wants to go home; dc'd to home with hospice; pt passed away at home
Dizziness; heart palpitations; shortness of breath; headache; This is a spontaneous report from a contactable consumer (patient). A 26-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: ER8730, expiration date: not reported), dose 1 via an unspecified route of administration on 27Mar2021 15:00 (age at vaccination: 26 Years) as DOSE 1, SINGLE for covid-19 immunisation at Pharmacy or Drug Store. The patient medical history and concomitant medications were not reported. No allergies to medications, food, or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine and the patient did not receive any other medications within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient had not been tested for COVID-19. On 09Apr2021, 13 days after the vaccination, the patient experienced dizziness, heart palpitations, headache, shortness of breath. The events resulted in doctor or other healthcare professional office/clinic visit. No treatment received for the adverse events. The outcome for events was not recovered. No follow-up attempts are needed. No further information is expected.
Dad reports patient fine throughout the night with no fever. Got up in morning of 10/8/21 with temp of 96.7. Dad was fixing breakfast about 1/2 later & noticed she looked glossy eyed. Took temp again & she was 99. A few min. later she began seizing . Dad called for ambulance Patient had a seizure for 30 min. resolved after 10mg dose of intranasal versed with some left sided twitching. Also given Ativan & 60mg/kilogram of Keppra. Had, lab work, CXR, EKG & CT of head. Patient transferred to Hospital for further evaluation after overnight stay.
Patient ate breakfast and had a Bloody Mary. Laid down for a nap and woke up with a rash on chest and upper right arm. Burning sensation but not itchy. Normally does not have reactions to alcohol.
Information has been received from the news media concerning a 17 year old female who was vaccinated with a dose of GARDASIL vaccine (yeast) (Batch #, Lot #, route and site of administration not reported). Subsequently the patient developed rash and then experienced progressive decline (what sounds like lethargy) months after vaccination with GARDASIL vaccine (yeast). The patient and her parents believe GARDASIL vaccine (yeast) is the cause. No additional information is expected.
Pfizer 4/10/21 and 5/1/21. Positive on 1/5/22
Pt recv vax on 11/3/98; 4 hr later pt exp fever (100F), achy joints, red/swollen arm, rash
9/20/14 5:00 PM received vaccination. 9/20/14 6:30-7:00 PM redness, itchy, swelling by injection site. 9/24/14 swelling, redness gone.
R Deltoid with skin atrophy/depigmentation at site of injection. Some itching. Onset 7 weeks after injection. Pt denied any excessive erythema or swelling at time of injection.
Fever Blister on Nose; This case was reported by a pharmacist via call center representative and described the occurrence of fever blister in a 69-year-old female patient who received Herpes zoster (Shingrix) (batch number CF9K4, expiry date 11th September 2021) for prophylaxis.   On 29th April 2019, the patient received Shingrix. On an unknown date, less than a week after receiving Shingrix, the patient experienced fever blister. On an unknown date, the outcome of the fever blister was unknown.   It was unknown if the reporter considered the fever blister to be related to Shingrix.  Additional details were provided as follows: The patient had developed fever blister on nose. The reporter asked the question that if the patient could take Valtrex without causing Shingrix to be less effective and gathered patient's information.
This spontaneous report was received from a registered nurse refers to a patient of unknown age and gender. On an unknown date, the patient was vaccinated with a dose of GARDASIL, (lot number, expiry date and route was not reported). On an unknown date, the patient received his second dose of GARDASIL, (lot number, expiry date and route was not reported), 27days after the first dose and no adverse effect reported. The outcome of patient received his second dose of GARDASIL 27days after 1st dose. No adverse effect was reported. Additional information has been requested.
MMR given in (R) arm SQ. Client states: "swollen lymph nodes under arm".
PATIENT CALLED US ON 02/16/19 ON SATURDAY & WAS COMPLAINING PAIN ALL OVER BODY & HE HAS DIFFICULTY IN WALKING.
Pt. reports that the next day, left arm was swollen from injection site to elbow and complained of pain.
passed out in aisle of store 5 min after receiving vaccine. mother and sister have history of passing out (vaso-vagel rxn). mother, neighbor and pharmacist sat him up in chair in aisle while 911 was called. all stayed with patient until emt arrived and patient left with them.
I?m experience erectile dysfunction and swollen  testicles. I?ve never experienced these symptoms before. They suddenly appeared some months after taking my vaccine shot. I?ve been healthy otherwise until now.
In the evening I had a little headache.  Woke up at 4:00AM with chills and the shivers and shakes.  Went back t0 bed with extra blankets.  Woke up around 8:AM with a temperature of 99.9 degrees.  My temperature went up to 100.6 degrees during the day.  At 3:30PM, temperature was  99.1 degrees.  At 4:00PM temperature was 98.6 degrees.  Also, I had joint and muscle aches, along with a headache.
This spontaneous report as received from a consumer via Clinic refers to a currently 2 year old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 16-MAR-2017, the patient was vaccinated with improperly stored dose of LIQUID PEDVAXHIB 1 dose unit (lot # M025193, Expiry date : 21-MAR-2019) for prophylaxis (product storage error). There were no previous temperature excursions recorded. It was unknown if data logger was involved. No adverse effects were reported. There was no product quality complaint involved.  This is one of the several reports received from the same reporter.; Sender's Comments: US-009507513-1801USA000166:
Mom reported that the pt woke up the following morning 26SEP91 extremely irritable; recvd a dose of APAP @ 1PM 26SEP-napped until 2PM; woke up very hot fever 104, listless & very cranky; MD instructed mom to take pt to ER;
arm became significantly inflamed; large welts; lymph nodes by my clavicle were huge; fever; chills; ACHES; HEADACHE; Nausea; This case was reported by a consumer and described the occurrence of inflammation localized in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced inflammation localized, welts, enlargement of lymph nodes, fever, chills, pain, headache and nausea. On an unknown date, the outcome of the inflammation localized, welts, enlargement of lymph nodes, fever, chills, pain, headache and nausea were unknown.   It was unknown if the reporter considered the inflammation localized, welts, enlargement of lymph nodes, fever, chills, pain, headache and nausea to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported. After receiving Shingrix, the patient's arm became significantly inflamed with large welts, lymph nodes by clavicle were huge, had a fever, chills, aches, headache and nausea. The patient was looking for the ingredients that were in the Shingrix shingles vaccine and want to know if the patient was allergic to this to prepare for 2nd dose and any other vaccines that might contain similar ingredients.
Prolonged general pain. Joint pain (sle flair type) extending since injection. (17 days @ time of submission)
Redness, erythema, and induration at the injection side getting progressively worse since vaccinated on 8/3/2022
HIB vaccine (ACTHib) administered right leg, causing swelling from knee top groin, erythema, pain and crying.
Concentrated intermittent upper left quadrant pain, then spreading throughout entire upper and lower abdomen region with constant pain turning into excruciating pain. Nausea, sudden profuse sweating, difficulty speaking, slurred speech, turned into not being able to speak, dizziness, some disorientation, death felt imminent, fading out, passed out, dry mouth, skin color yellowish-grey, clammy skin, extreme and sudden weakness, later chills, short, quickened breathing, then later, husband couldn't tell if breathing was happening or not (it was), felt small, soft lump in back of throat.  Hours later, extreme fatigue and weakness, followed by multiple intervals of sudden sweating throughout night. 2nd and 3rd day, fatigue, and neck pain and stiffness. 4th day: fatigue, mouth going dry several times during the day, neck pain and stiffness.
unable to lift arm; pain at injection site; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 76-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 26th December 2019, the patient received the 2nd dose of Shingrix (intramuscular). On 26th December 2019, less than a day after receiving Shingrix, the patient experienced injection site pain. On 2nd January 2020, the patient experienced injected limb mobility decreased. On an unknown date, the outcome of the injection site pain and injected limb mobility decreased were not recovered/not resolved.   It was unknown if the reporter considered the injection site pain and injected limb mobility decreased to be related to Shingrix.  Additional details were provided as follows: This case was reported by patient's husband. The patient received 2nd dose of Shingrix on the right deltoid. The patient experienced pain at injection site and was unable to lift her arm. The patient planned to continue follow-up with her physician on an unknown date. This case has been linked with case US2020033080 (husband's case), reported by the same reporter.
A non-serious spontaneous report of "administered H1N1 LAIV to 57 year old" was received from a pharmacist concerning a 57-year-old male. No relevant medical history have been reported for this patient. On 16-Nov-2009, the patient received H1N1, Intranasal. There was no adverse event associated with this medication error; therefore, treatment and reporter causality assessments were not applicable, and the event was considered as resolved.
Achy, fever 102 degrees F, chills, H/A, cough, fatigue, stomach upset, lightheaded, vomiting, shaky.
Pt recv vax & exp blurred vision & visual disturbances including jumpy eye. no further information
Red 2-inch square at site of injection. Began spreading shoulder to elbow, hot to touch, hardness of skin.
1/25/2021- severe pain at vaccination site, I could not move my arm, was unable to sleep. 1/26/2021- dizzy, achy, chills, fever 101.8 degrees to 102.6 degrees. 1/27/2021- slept most of the entire day, achy, dizzy. 1/28/2021 & 1/29/2021- fatigue.
1 of 4 pts vax from the same lot# exp an adverse event; pt recv OPV only 8SEP94 & parent reported that pt cried all noc following vax & was not himself; No MD visit or med prescribed; pt recovered;
This case was reported by a consumer via call center representative and described the occurrence of generalized muscle aches in a adult male patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, unknown after receiving SHINGRIX, the patient experienced generalized muscle aches and shallow breathing. On an unknown date, the outcome of the generalized muscle aches and shallow breathing were unknown. It was unknown if the reporter considered the generalized muscle aches and shallow breathing to be related to SHINGRIX. Additional details were provided as follows: The patient was transferred from GSK customer relations. The age at vaccination was not reported. The patient reported that he experienced severe muscle aches all over his body and shallow breathing (due to the severe muscle aches) after he received his 1st injection of the SHINGRIX. The reporter gave consent to follow up. Limited information was provided. The patient disconnected early in the conversation.
Three hours after 2nd Pfizer vaccine, patient developed swollen armpits, top of head hurting and fever of 102.
got sick with it; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, batch/lot and expiration date unknown), via an unspecified route of administration, administered in the right arm on 09Feb2021 at a single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced got sick with it (minor). The outcome of the event was not recovered per report "it is still lasting".  Information about lot/batch has been requested.
Patient received 5 to 11 years old Pfizer vaccine instead of the 12+ Adult Pfizer as his booster shot.  No side-effect has been reported yet. Patient consultation has been given after the vaccination by our County Pediatrician regarding this dosage error. No additional booster dose will be provided at this time. To our knowledge, there is currently no additional dose adviced at this moment.
This is a spontaneous report from a contactable consumer (patient). A 32-years-old non pregnant female patient reported for herself that she received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: EW0158), via an unspecified route, administered in arm left on 07Apr2021 (age at vaccination was 32 years) as DOSE 2, SINGLE for covid-19 immunization at school or student health clinic. No other vaccines were received in four weeks. Medical history was not reported. Known allergies included shrimp and sesame. Concomitant medications were not reported. The patient previously took Z-PAK and experienced allergies and bnt162b2 (Batch/Lot Number: ER2613), via an unspecified route, administered in arm left on 17Mar2021 at 02:00 PM (age at vaccination was 32 years) as DOSE 1, SINGLE for covid-19 immunization and experienced muscle aches, bad migraine and dizziness. On an unspecified date in Apr2021, the patient's neck lymph node was very swollen, only slightly on right which led to chest pain. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient was not tested for COVID-19. Outcome of the events was unknown. No follow up attempts are possible. No further information is expected.
pt recv vax OCT96 & 27DEC96 pt devel a sore throat followed by cough, fever & chills;